Don't eat me/eat me signals as a novel strategy in cancer immunotherapy
Authors:
- Amirreza KhalajiAKAmirreza Khalaji
- Fatereh Baharlouei YancheshmehFYFatereh Baharlouei Yancheshmeh
- Fatemeh FarhamFFFatemeh Farham
- Arya KhorramAKArya Khorram
- Shiva SheshboloukiSSShiva Sheshbolouki
- Maryam ZokaeiMZMaryam Zokaei
- Fatemeh VatankhahFVFatemeh Vatankhah
- Mehdi Soleymani-GoloujehMSMehdi Soleymani-Goloujeh
Open Access
Abstract
No abstract availableKeywords
This publication has 123 references indexed in Scilit:
- The CD47–SIRPα pathway in cancer immune evasion and potential therapeutic implicationsCurrent Opinion in Immunology, 2012
- Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcomaProceedings of the National Academy of Sciences, 2012
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumorsProceedings of the National Academy of Sciences, 2012
- Constitutive exposure of phosphatidylserine on viable cellsProceedings of the National Academy of Sciences, 2011
- Beginnings of a Good Apoptotic Meal: The Find-Me and Eat-Me Signaling PathwaysImmunity, 2011
- Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearanceNature, 2009
- Structure of Signal-regulatory Protein αJournal of Biological Chemistry, 2009
- The ins and outs of phospholipid asymmetry in the plasma membrane: roles in health and diseaseCritical Reviews in Biochemistry and Molecular Biology, 2009
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem CellsCell, 2009
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapyNature Medicine, 2007